Revenue
0 USD
2020 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
17 filing records in this dataset, filed from 2016-10-14 to 2020-08-25. Reported financial figures are available; chart coverage varies by period.
0 USD
2020 Q3 · USD
-27.6 thousand USD
2020 Q3 · USD
-27.6 thousand USD
2020 Q3 · USD
3791 USD
1488832800 shares
203,114.78% · 1.49 billion shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2020-08-25.
Financial data available through: 2019-08-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 1.32 million
–
Current period
−USD 3.61 million
–
-3612542 − -1322940 = -2289602 USD
-1322940 USD · 2017-09-01 – 2018-08-31
Inspect prior input Prior source-3612542 USD · 2018-09-01 – 2019-08-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 950,087
–
Current period
−USD 1.92 million
–
-1924111 − -950087 = -974024 USD
-950087 USD · 2017-09-01 – 2018-08-31
Inspect prior input Prior source-1924111 USD · 2018-09-01 – 2019-08-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 178,678
–
Current period
−USD 611,759
–
-611759 − -178678 = -433081 USD
-178678 USD · 2017-09-01 – 2018-08-31
Inspect prior input Prior source-611759 USD · 2018-09-01 – 2019-08-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2017 2016-09-01 – 2017-08-31 | 35100 | 53632 Derived | -18532 | 0 Derived | -18532 | Unavailable | Source
|
| 2019 2018-09-01 – 2019-08-31 | 3529064 | 7214158 Derived | -3685094 | -72552 Derived | -3612542 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Revenue | 35100 |
|
| 2019 | Revenue | 3529064 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Year over year | No prior comparable period |
|
| 2019 | Year over year | No prior comparable period |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Operating margin | -52.8% |
|
| 2019 | Operating margin | -104.4% |
|
| 2017 | Net margin | -52.8% |
|
| 2019 | Net margin | -102.4% |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Operating cash flow | -8301 |
|
| 2019 | Operating cash flow | -1924111 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Liabilities / assets | 67.3% |
|
| 2019 | Liabilities / assets | 447.5% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017-08-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2019 | Current assets / current liabilities | 0.05× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2017 2016-09-01 – 2017-08-31 | −USD 18,532 Exact valueExact value: -18532 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8,301 Exact valueExact value: -8301 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable The mapped spending value is negative, so its direction is unclear. | Unavailable Capital expenditure has a negative mapped value; spending direction is unclear. |
| 2018 2017-09-01 – 2018-08-31 | −USD 1.32 million Exact valueExact value: -1322940 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 950,087 Exact valueExact value: -950087 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable The mapped spending value is negative, so its direction is unclear. | Unavailable Capital expenditure has a negative mapped value; spending direction is unclear. |
| 2019 2018-09-01 – 2019-08-31 | −USD 3.61 million Exact valueExact value: -3612542 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.92 million Exact valueExact value: -1924111 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable The mapped spending value is negative, so its direction is unclear. | Unavailable Capital expenditure has a negative mapped value; spending direction is unclear. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
17 filings · 866 latest values · 848 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001684508, 1684508, cann, edgar:1684508, zartex
Also known as CANNIS, INC., Cannis, Inc., Cannis, Inc.., ZARTEX INC., Zartex Inc.